Search bioRxiv⌕ Search

bioRxiv · 10.1101/677195

A novel approach for combining task-dependent gamma with alpha and beta power modulation for enhanced identification of eloquent cortical areas using ECoG in patients with medical-refractory epilepsy

Abstract

Electrical stimulation mapping (ESM) is the gold standard for identification of \"eloquent\" areas prior to resection of epileptogenic tissue, however, it is time consuming and may cause side effects, especially stimulation-induced seizures and after-discharges. Broadband gamma activity (55 - 200 Hz) recorded with subdural electrocorticography (ECoG) during cognitive tasks has been proposed as an attractive tool for mapping cortical areas with specific function but until now has not proven definitive clinical value. Fewer studies have addressed whether the alpha (8 - 12 Hz) and beta (15 - 25 Hz) band activity could also be used to improve eloquent cortex identification. We compared alpha, beta and broadband gamma activity, and their combination for the identification of eloquent cortical areas defined by ESM. Ten patients participated in a delayed-match-to-sample task, where syllable sounds were matched to visually presented letters and responses given by keyboard. We used a generalized linear model (GLM) approach to find the optimal weighting of low frequency bands and broadband gamma power to predict the ESM categories. Broadband gamma activity increased more in eloquent areas than in non-eloquent areas and this difference had a diagnostic ability (area under (AU) the receiving operating characteristic curve - AUROC) of [~]70%. Both alpha and beta power decreased more in eloquent areas. Alpha power had lower AUROC than broadband gamma while beta had similar AUROC. AUROC was enhanced by the combination of alpha and broadband gamma (3% improvement) and by the combination of beta and broadband gamma (7% improvement) over the use of broadband gamma alone. Further analysis showed that the relative performance of broadband gamma and low frequency bands depended on multiple factors including the time period of the cognitive task, the location of the electrodes and the patients attention to the stimulus. However, the combination of beta band and broadband gamma always gave the best performance. We show how ECoG power modulation from cognitive testing periods can be used to map the probability of eloquence by ESM and how this probability can be used as an aid for optimal ESM planning. We conclude that low frequency power during cognitive testing can contribute to the identification of eloquent areas in patients with focal refractory epilepsy improving its precision but does not replace the need of ESM.\n\nHighlightsO_LIGamma, alpha and beta band activity has significant diagnostic ability to identify ESM defined eloquent cortical areas.\nC_LIO_LIWe present a novel method to combine gamma and low frequency activity for enhanced identification.\nC_LIO_LIWe quantify how identification is dependent on analysis time window, cortical function, and patients attentional engagement.\nC_LIO_LIWith further development, this approach may offer an alternative to ESM mapping with reduced burden for patients.\nC_LI

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Archila-Melendez, M. E., Valente, G., Gommer, E., Rouhl, R. P. W., Schijns, O. E. M. G., Dings, J. T. A., Hilkman, D. M. W., Jansma, B. M., van Kranen-Mastenbroek, V. H. J. M., Roberts, M. J.. 2019-06-20. A novel approach for combining task-dependent gamma with alpha and beta power modulation for enhanced identification of eloquent cortical areas using ECoG in patients with medical-refractory epilepsy. https://doi.org/10.1101/677195

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Rab10 and Arhgef7 interact to promote axon extension by linking vesicle supply and exocytosis

The formation of functional neural circuits begins with the extension of a single axon by immature neurons. Axon elongation requires an expansion of the plasma membrane that depends on the polarization of vesicle trafficking and exocytosis. It is not completely understood how the increased transport of vesicles into the growing axon is linked to their subsequent insertion into the plasma membrane. An analysis of early stages of neuronal differentiation indicates that an asymmetry in neurite length precedes axon specification and the accumulation of PPVs in the nascent axon. We show that increasing the transport of vesicles in unpolarized neurons is sufficient to promote the extension of additional axons. This effect indicates that an increased supply of vesicles stimulates their subsequent insertion into the membrane to allow neurite growth. The link between vesicle transport and exocytosis is mediated by the interaction of Rab10 with Arhgef7. Rab10 stimulates Arhgef7 activity on PPVs as a GEF for Cdc42b to promote axon extension through exocyst-dependent exocytosis, suggesting that their interaction links the increased supply of PPVs to their exocytosis.

neuroscience↗

Subcellular Spatial Profiling Unveils Links Between Neuritic Plaques with Selective Tau Vulnerability in Alzheimer's Disease

Alzheimer's disease (AD) features widespread extracellular amyloid-{beta} plaques but selective intraneuronal tau accumulation in cortical layers II/III and V, while layer IV remains relatively resistant. Here, we combined subcellular spatial transcriptomics with co-registered A{beta} and pTau immunohistochemistry to determine why neurons exposed to comparable plaque-associated pathology differ in somatic pTau accumulation. Plaque-associated neuritic stress occurred similarly across layers, but layer IV neurons showed attenuated pTau accumulation and reduced somatic expression of a shared neurite-soma stress program involving DCTN1, CALM3, NORAD, and PIN1. Trajectory analysis within layers identified tau-vulnerable and resistant neuronal states implicating calcium signaling, retrograde transport, and lysosomal function. Notably, astrocytic APOE-neuronal LRP1 co-expression increased significantly along the pTau-vulnerable trajectory, and APOE {epsilon}4 was associated with stronger coupling of local plaque pathology to pTau-associated molecular programs. These findings reveal neuronal programs and neuron-glia interactions underlying selective tau vulnerability and resistance in AD, highlighting potential tau-targeting therapeutics.

neuroscience↗

Widespread oscillatory suppression in autism persists in the absence of psychotropic medication.

Purpose: Investigate the neural oscillatory activity associated with autism spectrum disorder (ASD) using electroencephalographic (EEG) recordings in children and adolescents. Compare the corresponding oscillatory power between ASD patients taking psychotropic medication with a drug-naive group. Methods: ASD diagnosis was done using DSM-IV and CARS (Childhood Autism Rating Scale). EEG recordings employed 22 scalp electrodes (10/20 system). ASD vs. neurotypical groups were matched for sex and age (5 females; average age: ~10 years old). We analyzed the resting state (eyes open) EEG power spectrum during ~2-minute recordings. The multitaper FFT method was used to estimate spectral power for the delta, theta, alpha, beta and gamma frequency bands. We pooled together data from several electrodes to compute comprehensive power spectra and assess the oscillatory behavior of macro brain regions. Results: We observed widespread (~4Hz - 20Hz) oscillatory suppression comprising the theta, alpha and beta frequency bands. The most widespread and robust ASD-associated power suppression was in the high theta and alpha bands. Delta and gamma bands showed no significant power change for any of the brain regions studied. Results from a subgroup of patients (N = 9) who never used psychotropics confirmed these findings, indicating that they are not an artifact of medication. Conclusion: Suppression in theta, alpha and beta oscillations may offer insights into the neurophysiological underpinnings of autism and could be used as an accessible and comprehensive tool in ASD diagnosis, regardless of the patients being or not on medication.

neuroscience↗